 | • レポートコード：MRC2303F0065 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、248ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査資料によると、2021年に988.93百万ドルであった世界の生検ガイダンス装置市場規模が、2022年に1,048.96百万ドルになり、予測期間中（〜2027年）にCAGR6.24%で成長し1,422.55百万ドルまで達すると展望されています。本書は、生検ガイダンス装置の世界市場について総合的に分析し、市場規模・動向・予測などを整理しています。序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品別（MRIガイド下生検、定位ガイド下生検、超音波ガイド下生検）分析、用途別（脳内生検、乳房生検）分析、エンドユーザー別（診断センター、病院、研究・学術機関、専門クリニック）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報など、以下の構成で掲載しています。また、主要企業として、ARGON MEDICAL、B. Braun Melsungen AG、Becton, Dickinson and Company、Boston Scientific Corporation、C. R. Bard, Inc.、Cardinal Health, Inc.、Cook Medical、Fujifilm Holdings Corporation、Gallini Medical、Hologic, Inc.、INRAD Inc.、Medtronic PLC、Olympus Corporation、PLANMED OY、Siemens Healthineersなどの情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の生検ガイダンス装置市場規模：製品別 - MRIガイド下生検の市場規模 - 定位ガイド下生検の市場規模 - 超音波ガイド下生検の市場規模 ・世界の生検ガイダンス装置市場規模：用途別 - 脳内生検における市場規模 - 乳房生検における市場規模 ・世界の生検ガイダンス装置市場規模：エンドユーザー別 - 診断センターにおける市場規模 - 病院における市場規模 - 研究・学術機関における市場規模 - 専門クリニックにおける市場規模 ・世界の生検ガイダンス装置市場規模：地域別 - 南北アメリカの生検ガイダンス装置市場規模 アメリカの生検ガイダンス装置市場規模 カナダの生検ガイダンス装置市場規模 ブラジルの生検ガイダンス装置市場規模 … - アジア太平洋の生検ガイダンス装置市場規模 日本の生検ガイダンス装置市場規模 中国の生検ガイダンス装置市場規模 インドの生検ガイダンス装置市場規模 韓国の生検ガイダンス装置市場規模 台湾の生検ガイダンス装置市場規模 … - ヨーロッパ/中東/アフリカの生検ガイダンス装置市場規模 イギリスの生検ガイダンス装置市場規模 ドイツの生検ガイダンス装置市場規模 フランスの生検ガイダンス装置市場規模 ロシアの生検ガイダンス装置市場規模 … - その他地域の生検ガイダンス装置市場規模 ・競争状況 ・企業情報 |
The Global Biopsy Guidance System Market size was estimated at USD 988.93 million in 2021 and expected to reach USD 1,048.96 million in 2022, and is projected to grow at a CAGR 6.24% to reach USD 1,422.55 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Biopsy Guidance System to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the market was studied across MRI Guided Biopsy, Stereotactic Guided Biopsy, and Ultrasound Guided Biopsy.
Based on Application, the market was studied across Brain Biopsy and Breast Biopsy.
Based on End-use, the market was studied across Diagnostic Centers, Hospitals, Research and Academic Institutes, and Specialty Clinics.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Biopsy Guidance System market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Biopsy Guidance System Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Biopsy Guidance System Market, including ARGON MEDICAL, B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, C. R. Bard, Inc., Cardinal Health, Inc., Cook Medical, Fujifilm Holdings Corporation, Gallini Medical, Hologic, Inc., INRAD Inc., Medtronic PLC, Olympus Corporation, PLANMED OY, and Siemens Healthineers.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Biopsy Guidance System Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biopsy Guidance System Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biopsy Guidance System Market?
4. What is the competitive strategic window for opportunities in the Global Biopsy Guidance System Market?
5. What are the technology trends and regulatory frameworks in the Global Biopsy Guidance System Market?
6. What is the market share of the leading vendors in the Global Biopsy Guidance System Market?
7. What modes and strategic moves are considered suitable for entering the Global Biopsy Guidance System Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of cancer
5.1.1.2. Rising preference for minimally invasive biopsy treatments
5.1.1.3. Increasing government and non-government initiatives related to the biopsy guidance
5.1.2. Restraints
5.1.2.1. High cost associated with biopsy guidance system
5.1.3. Opportunities
5.1.3.1. Continuous technological advancements such as robot-assisted biopsy guidance systems, needle-based biopsy guns
5.1.3.2. Rising awareness of breast cancer treatment and diagnosis
5.1.4. Challenges
5.1.4.1. Complications associated with imaging systems
5.2. Cumulative Impact of COVID-19
6. Biopsy Guidance System Market, by Product
6.1. Introduction
6.2. MRI Guided Biopsy
6.3. Stereotactic Guided Biopsy
6.4. Ultrasound Guided Biopsy
7. Biopsy Guidance System Market, by Application
7.1. Introduction
7.2. Brain Biopsy
7.3. Breast Biopsy
8. Biopsy Guidance System Market, by End-use
8.1. Introduction
8.2. Diagnostic Centers
8.3. Hospitals
8.4. Research and Academic Institutes
8.5. Specialty Clinics
9. Americas Biopsy Guidance System Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Biopsy Guidance System Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Biopsy Guidance System Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. ARGON MEDICAL
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. B. Braun Melsungen AG
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Becton, Dickinson and Company
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Boston Scientific Corporation
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. C. R. Bard, Inc.
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Cardinal Health, Inc.
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Cook Medical
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Fujifilm Holdings Corporation
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Gallini Medical
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Hologic, Inc.
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. INRAD Inc.
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Medtronic PLC
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Olympus Corporation
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. PLANMED OY
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Siemens Healthineers
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing